Heberprot-p was created by a team of researchers from the Center for Genetic Engineering and Biotechnology (CIGB)
The next meeting of the Russia-Cuba Health Working Group Intergovernmental Commission will be held in May
Unique in the world to treat advanced foot ulcers in diabetic patients, the Cuban drug Heberprot-P has already been registered in 23 countries, it was informed today
Specialists from at least 40 countries will assist to the International Congress “Controlling diabetes and its most severe complications”, to take place December 10th to 12th, in Varadero.
Cuba reduced by over 78 percent the relative risk of amputation due to diabetic foot ulcers, thanks to a comprehensive program of care for these patients that includes the use of the drug Heberprot-P.
Russia’s Health Minister Veronika Skortsova stressed in Moscow the quality of the Cuban biotechnology industry and expressed her interest in having a larger presence of Cuban pharmaceuticals in her country.
Belarus will apply Cuban unique drug worldwide to heal diabetic foot Heberprot-P, according to an agreement signed here, highlighted the Belarusian media.
Heberprot-P is a unique drug developed in Cuba.
The Cuban product Heberprot-p, to cure complaints resulting from diabetes, is welcomed in Ecuador for the results reported by patients with treatment in this South American country.
Introduced five years ago Heberprot-p, the Cuban drug to treat diabetic foot ulcers, has proven effectiveness: after its application the rates of amputations in patients suffering from this disease have decreased.